Literature DB >> 12990356

Benefits and toxicity of phenylbutazone (butazolidin) in rheumatoid arthritis.

C A L STEPHENS, E E YEOMAN, W P HOLBROOK, D F HILL, W L GOODIN.   

Abstract

Entities:  

Keywords:  ANALGESICS/therapeutic use; ARTHRITIS, RHEUMATOID/therapy

Mesh:

Substances:

Year:  1952        PMID: 12990356     DOI: 10.1001/jama.1952.03680110024007

Source DB:  PubMed          Journal:  J Am Med Assoc        ISSN: 0002-9955


× No keyword cloud information.
  14 in total

1.  An appraisal of phenylbutazone suppositories.

Authors:  C F HAWKINS; H T FAWNS
Journal:  Br Med J       Date:  1959-10-17

2.  [Action mechanism of butazolidine; effects on the heparin tolerance test and on the erythrocyte sedimentation rate in vitro].

Authors:  W BEIGLBOCK; H KAISER
Journal:  Klin Wochenschr       Date:  1956-05-15

3.  Metabolic effect of phenylbutazone in gouty and non-gouty arthritis.

Authors:  E R HUFFMAN; G M WILSON; C J SMYTH; R HILL
Journal:  Ann Rheum Dis       Date:  1954-12       Impact factor: 19.103

4.  BENEFITS and dangers of butazolidin.

Authors: 
Journal:  Br Med J       Date:  1952-12-27

5.  Comparative effects of ACTH and butazolidin in rheumatoid arthritis.

Authors:  R M MASON
Journal:  Ann Rheum Dis       Date:  1953-06       Impact factor: 19.103

6.  Observations on the treatment of rheumatoid arthritis with butazolidin.

Authors:  J P CURRIE; R A BROWN; G WILL
Journal:  Ann Rheum Dis       Date:  1953-06       Impact factor: 19.103

7.  Toxic effects of phenylbutazone with special reference to disorders of the blood.

Authors:  J C LEONARD
Journal:  Br Med J       Date:  1953-06-13

8.  ANNOTATIONS.

Authors: 
Journal:  Br Med J       Date:  1962-02-17

9.  Biopharmaceutical properties of solid dosage forms.

Authors:  R A Chapman
Journal:  Can Med Assoc J       Date:  1967-09-16       Impact factor: 8.262

10.  The biopharmaceutical properties of solid dosage forms. I. An evaluation of 23 brands of phenylbutazone tablets.

Authors:  R O Searl; M Pernarowski
Journal:  Can Med Assoc J       Date:  1967-06-10       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.